Cementos Pacasmayo S.A.A. (CPAC)
NYSE: CPAC · Real-Time Price · USD
5.79
-0.15 (-2.45%)
Nov 22, 2024, 3:59 PM EST - Market closed
Cementos Pacasmayo Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Cementos Pacasmayo stock has a target of 6.00, which predicts an increase of 3.72% from the current stock price of 5.79.
Analyst Consensus: Sell
* Price targets were last updated on Aug 21, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for CPAC is "Sell". This means that the analyst believes this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Hold → Sell Downgrades $6 | Hold → Sell | Downgrades | $6 | +3.72% | Aug 21, 2024 |
B of A Securities | B of A Securities | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Mar 7, 2018 |
Barclays | Barclays | Hold Maintains $11 → $12 | Hold | Maintains | $11 → $12 | +107.43% | Oct 27, 2017 |
B of A Securities | B of A Securities | Sell Maintains $9.9 → $11 | Sell | Maintains | $9.9 → $11 | +90.15% | Jul 21, 2017 |
Barclays | Barclays | Buy → Hold Downgrades $11 → $9 | Buy → Hold | Downgrades | $11 → $9 | +55.57% | Oct 27, 2014 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.